🇺🇸 FDA
Pipeline program

SSGJ-705

SSGJ-705-201

Phase 2 small_molecule active

Quick answer

SSGJ-705 for Locally Advanced, Recurrent or Metastatic Malignancies is a Phase 2 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Locally Advanced, Recurrent or Metastatic Malignancies
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials